Daiichi Sankyo 4568Maker of the cancer drug Enhertu
5.99 % of fund value
Japanese drug maker that developed the breast cancer drug Enhertu with AstraZeneca
MFC JAPAN Equity Fund
Shows where this fund stands in its group. Not investment advice · Data as of 4 Nov 2026
MJAPAN invests through the master fund Arcus Japan Fund 107.04%
This fundMJAPAN
The fund that actually investsArcus Japan FundThis fund and the master fund each charge their own fees. See the fees section of this page for the actual fees
Daiichi Sankyo 45685.99%
NTT 94325.78%Data as of 30 Sep 2026 · Top 6 shown, the rest grouped as Other · per Arcus fact sheet · Country inferred from the name of a single-country fund
Launched less than a year ago, so no 1-year rank yet
Each bar is one fund in the AIMC Japan Equity group, sorted from highest to lowest return · Every share class is counted, and only funds with a full track record for the period are included · Calculated from NAV as of 4 Nov 2026
Past performance is not a guarantee of future results
| 1W | 2W | 1M | 3M | 6M | MAX |
|---|---|---|---|---|---|
| +0.05% | −1.49% | +1.10% | +1.62% | +11.07% | +11.69% |
Total return over each period, matching the NAV chart periods · Not annualised
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Full year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | · | +9.6 | −9.0 | +0.8 | +6.1 | −1.5 | +6.1 | +5.1 | −3.4 | −0.9 | −0.4 | · |
Largest drawdown in the selected period −10.04% Previous peak 27 Feb 2026 (NAV 10.9574) → Trough 23 Mar 2026 (NAV 9.8571) · Back to the previous peak on 6 Jul 2026, after 3 months
Currently −6.03% from the peak NAV of 11.8859 (1 Sep 2026)
Over 1 year, 34 funds have data · MJAPAN has no data for this period yet
กองทุนมีนโยบายลงทุนในหน่วยลงทุนของกองทุนรวมต่างประเทศเพียงกองทุนเดียว (Feeder Fund) คือ Arcus Japan Fund (กองทุนหลัก) ชนิดหน่วยลงทุน (share class) “A ACC USD Hedged” ในสกุลเงินดอลลาร์สหรัฐ โดยเฉลี่ยในรอบปีบัญชีไม่น้อยกว่าร้อยละ 80 ของมูลค่าทรัพย์สินสุทธิของกองทุนรวม ซึ่งกองทุนหลักจดทะเบียนจัดตั้งท… Its largest holdings are Arcus Japan Fund 108.46% (fact sheet 31 Aug 2026)
Risk level 6 of 8 (High risk). Since 30 Jan 2026, its NAV has fallen as much as −10.04% from its peak.
Actual total expense ratio (TER) 1.96% a year, against a ceiling of 4.89%. Management fee 1.61%. Front-end fee 1.50%. Back-end fee 0.00%. (Fact sheet 31 Aug 2026)
No. Gains or losses accumulate in the NAV, and investors receive their return when they redeem units
Minimum first purchase 1,000 THB, subsequent purchases 1,000 THB. Buy orders accepted until 15:30, sell orders until 15:30, and redemption proceeds are paid T+6
Hedged at the manager's discretion. As of 31 Aug 2026, 87.00% of the value of its foreign investments was hedged
Past performance is not a guarantee of future results · Investing involves risk. Investors should understand the product's features, return conditions and risks before making an investment decision · This fund invests abroad, so investors may lose or gain from exchange rate movements
Asahi 25024.71%
Rakuten 47554.17%
Nissan Motor 72013.43%
Japan Post 61783.43%
Honda Motor 72673.10%Daiichi Sankyo 4568Japanese drug maker that developed the breast cancer drug Enhertu with AstraZeneca
NTT 9432Japanese telecoms group that owns the NTT Docomo mobile network and data centre services
Nidec 6594Japanese company that makes electric motors for hard drives, appliances, EVs and AI servers
Asahi 2502Japanese drinks company that owns Asahi Super Dry, Peroni and Pilsner Urquell beers
Rakuten 4755Japanese company running the Rakuten Ichiba online marketplace plus a mobile network, bank and credit cards
Cars, batteries and car parts
Japan Post 6178Japan's postal group, delivering letters and parcels and owning Japan Post Bank and Kampo life insurance
Japanese company that tests and quality checks software for businesses to catch bugs before launch
Cars, batteries and car parts
Makes and sells food and drinks, and runs restaurants
Based on the master fund's share of this fund's value (107.04% as of 31 Aug 2026) × each stock's weight in the master fund · stocks as of 30 Sep 2026 · fact sheet from Arcus · Illustrations are for explanation only, not individual stock recommendations
| +11.7* |